Antimicrobial resistance analysis, data analysis & visualisation

Molcular Genetics, Bacteriology, Medical Microbiology, Infection prevention

Infectious diseases, clinical microbiology, infection prevention

Methicillin-resistant S. aureus (MRSA)
Prevention of Antibiotic Resistance and Healthcare-associated infections
Crossborder (NL/DE) comparative research of health systems
Network analysis and transmission dynamics for infection prevention 

Corinna Glasner is scientific project manager for the leadpartner of the two INTERREG V projects EurHealth-1Health and health-i-care and research associate at the Department of Medical Microbiology and Infection Prevention. Her expertise lies in molecular microbiology and local, national and international epidemiology of pathogens. She successfully completed her PhD at the end of 2014 with numerous publications on the subtyping and genomic population structure of major pathogens of hospital infections, such as Staphylococcus aureus. Here she led u.a. Europe-wide prevalence of S. aureus and carbapenemase-producing Enterobacteriaceae (CPE). The avoidance of antibiotic resistance and the strengthening of infection prevention are also her area of ​​interest during this time. Since 2016, Corinna Glasner has been a central part of German-Dutch cooperation in the current INTERREG project EurHealth-1Health and health-i-care and is learning and living the opportunities of this exciting border region every single day.

Protein Crystallography
Biophysics
Structure-based Drug Design

NWO-VENI laureate Prof. Hak and his multidisciplinary team have supervised >30 PhD theses on the validity of scientific statistical and epidemiological causal design methods to assess (side-) effects of drugs and vaccines using Real-World Big Health Care and Biobank Data. Scientific methods consider a variety of designs such as case-control, cohort, case-only, sibling designs, instrumental variable analysis, propensity score analysis often in combination with RCTs, meta-analyses and Individual Patient Data designs. His scientific work led to >400 peer-reviewed publications till 2021 (Web of Science H-index 44, >8,000 citations). As leader of the PharmLines Initiative,  a public-private collaboration between Lifelines BV-UMCG-RUG, he initiates and co-supervises research in the area of Precision Medicine with linked biobank, genetic, clinical, pharmacological and health care data of >80,000 persons from the Northern region. Topics mainly concern the pharmaco-epidemiology of preventive medications as well as vaccinations. In addition, his team supports the societal impact by studying the optimal methods to implement innovations in the area of sustainable drug applications and  vaccination strategies (e.g. drug repurposing, data science technologies to support optimal drug use, development of infection risk profiles and vaccination passport).

Prof. Hak is program director of the two-year Groningen Research Master Medical Pharmaceutical Sciences. As a director he implemented innovations regarding the extension of research tracks including Pharmaceutical Design & Engineering, Drug Toxicology &Translational Technologies and Pharmacoepidemiology & -Economics. With these tracks the complete drug development cycle can be studied within MPS. He further introduced a strong mentorate for students, monitoring of research projects, clear selection criteria for examiners and committee evaluations of research projects, which resulted in a Top-label in 2017 and 2019 by the influential Dutch Keuzegids (MPS belongs to the top-10% best master educations in the Netherlands). As educational director Pharmacy (>100 faculty) he applies his broad expertise to lead the cluster Pharmacy, also in close collaboration with sister Faculties.

Microbiology; especially gastrointestinal ecology , pre- and probiotic.

Immunology of vaccinations. Immunological ageing. Biomarkers of vaccination. 

Health economics of blood transfusion safety, hematology and infectious diseases.

Data analysis & visualization | Teaching R

Development and implementation of molecular diagnostics in clinical virology. Implementation of international quality control programmes. Implementation of Point-of-Impact technologies. Cost/benefits studies. MiddleWare solutions in molecular diagnostics.

Klinische epidemiologie

Development and implementation of molecular tools for diagnosing infectious diseases. Focus on the use of sequence-based technologies for infection control, detection and understanding of antimicrobial resistance, and the role of the host in the disease course of an infection.

Research project: de klinische toepasbaarheid van Next-Generation Sequencing technieken om interventies in het pathogene orale microbioom aan te tonen

Antibioticabeleid binnen de Tandheelkunde

Research unit: Microbes in Health and Disease (MHD)
Research unit: Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)
Research Institute: GUIDE

Infectious diseases, mycobacteria, HIV, clinical epidemiology, internal medicine

Clinical and field epidemiology, molecular epidemiology, temporo-spatial analysis of disease spread, qualitative studies and public health of infectious diseases in the tropics and sub-tropics.

Infectiepreventie

Board-Certified training: Pulmonary Diseases & Tuberculosis, Experience, former: Tropical Medicine; Critical Care. Present Position: head, Infectious Diseases

Universal Health Coverage, Global Health Education, Research Capacity Building, Mixed-Methods Research